SLXN

Silexion Therapeutics Corp

May 15 • 04:00PM ET

0.2890

-0.2098 -42.06 %

Healthcare • Biotechnology • Israel • Nano • NASD

Peers: LIXT TNXP PALI SABS BCDA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-12.45	Insider Own	7.13%	Shs Outstand	4.07M	Perf Week	-44.95%
Market Cap	1.18M	Forward P/E	-	EPS next Y	-2.23	Insider Trans	-7.29%	Shs Float	3.78M	Perf Month	-71.10%
Enterprise Value	-2.80M	PEG	-	EPS next Q	-1.29	Inst Own	1.14%	Short Float	0.88%	Perf Quarter	-81.82%
Income	-11.91M	P/S	-	EPS this Y	54.02%	Inst Trans	0.25%	Short Ratio	0.41	Perf Half Y	-90.07%
Sales	0.00M	P/B	0.35	EPS next Y	45.87%	ROA	-236.40%	Short Interest	0.03M	Perf YTD	-84.95%
Book/sh	0.83	P/C	0.20	EPS next 5Y	33.21%	ROE	-771.23%	52W High	22.36 -98.71%	Perf Year	-98.00%
Cash/sh	1.47	P/FCF	-	EPS past 3/5Y	- -38.17%	ROIC	-267.26%	52W Low	0.46 -37.26%	Perf 3Y	-99.98%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	22.22% 16.18%	Perf 5Y	-99.98%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	95.85%	Oper. Margin	-	ATR (14)	0.11	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.41	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	18.96	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.41	EPS Q/Q	90.04%	SMA20	-56.35%	Beta	-0.31	Target Price	6.00
Payout	-	Debt/Eq	0.78	Sales Q/Q	-	SMA50	-72.93%	Rel Volume	55.26	Prev Close	0.50
Employees	14	LT Debt/Eq	0.71	Earnings	Mar 17 AMC	SMA200	-90.35%	Avg Volume	80.33K	Price	0.29
IPO	Apr 07, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	-112.95% -	Trades		Volume	4,438,956	Change	-42.06%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)